AAV vector optimization, in vitro modeling and therapeutic testing (2D and 3B platforms) and in vivo delivery for tissue‑targeted gene transfer to heart and muscle, neurological tissues. Testing and therapeutic improvement of mitochondrial function in the context of various disease states. Work includes promoter design, systemic and direct administration dosing, and translational models of cardiomyopathy, DNA repair disorders, and muscular dystrophies.